Literature DB >> 15985817

Bee venom allergy in beekeepers and their family members.

Ulrich R Müller1.   

Abstract

PURPOSE OF REVIEW: To analyze prevalence of allergic sting reactions, including the clinical and diagnostic features as well as management options in a population heavily exposed to honeybee stings such as beekeepers and their family members. RECENT
FINDINGS: The higher sting frequency is associated with an increased prevalence of allergic sting reactions. Major risk factors for allergic sting reactions in beekeepers are: fewer than 10 annual stings, an atopic constitution and symptoms of upper respiratory allergy during work in the beehive. Bee venom allergic beekeepers have higher levels of bee venom-specific IgG but lower skin sensitivity and bee venom-specific IgE than normally exposed bee venom allergic patients. Safety of bee venom immunotherapy is higher in beekeepers than in allergic controls, while efficacy of this treatment is similar in both groups.
SUMMARY: Beekeepers and their family members are at an increased risk of severe sting anaphylaxis and therefore need especially careful instruction with regard to avoidance of re-exposure, emergency treatment and specific immunotherapy with bee venom.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985817     DOI: 10.1097/01.all.0000173783.42906.95

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  26 in total

Review 1.  Allergy in an Evolutionary Framework.

Authors:  Alvaro Daschner; Juan González Fernández
Journal:  J Mol Evol       Date:  2019-06-07       Impact factor: 2.395

Review 2.  Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Authors:  Stephen J Galli; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

3.  Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy[].

Authors:  Stephen J Galli; Martin Metz; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Allergo J Int       Date:  2020-03-02

4.  IgE, IgM, and IgG4 anti-desmoglein 1 autoantibody profile in endemic pemphigus foliaceus (fogo selvagem).

Authors:  Ye Qian; Phillip Prisayanh; Eugenio Andraca; Bahjat F Qaqish; Valeria Aoki; Gunter Hans-Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

Review 5.  Update on fogo selvagem, an endemic form of pemphigus foliaceus.

Authors:  Valeria Aoki; Evandro A Rivitti; Luis A Diaz
Journal:  J Dermatol       Date:  2015-01       Impact factor: 4.005

6.  It is time to beelieve the CD1a hype!

Authors:  Sai Harsha Krovi; Laurent Gapin
Journal:  Eur J Immunol       Date:  2016-01       Impact factor: 5.532

7.  Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.

Authors:  J Kärner; A Meager; M Laan; J Maslovskaja; M Pihlap; A Remm; E Juronen; A S B Wolff; E S Husebye; K T Podkrajšek; N Bratanic; T Battelino; N Willcox; P Peterson; K Kisand
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

Review 8.  The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis.

Authors:  Stephen J Galli
Journal:  Am J Pathol       Date:  2016-02       Impact factor: 4.307

9.  IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity.

Authors:  Philipp Starkl; Thomas Marichal; Nicolas Gaudenzio; Laurent Lionel Reber; Riccardo Sibilano; Mindy Tsai; Stephen Joseph Galli
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

Review 10.  Testing the 'toxin hypothesis of allergy': mast cells, IgE, and innate and acquired immune responses to venoms.

Authors:  Mindy Tsai; Philipp Starkl; Thomas Marichal; Stephen J Galli
Journal:  Curr Opin Immunol       Date:  2015-07-23       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.